Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Insider Changes in Ownership
  7. 4 Open-market buy See Explanation of Responses bought 170,000 shares at $5.25 ($892,500)
  8. 4 Open-market buy See Explanation of Responses bought 30,000 shares at $5.25 ($157,500)
  9. 4 Option exercise President & CEO acquired 1,000 shares (option exercise)
  10. 4 Open-market buy Director bought 2,000 shares at an average $5.43 ($10,861)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 4,000 shares at $5.19 ($20,760)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Option exercise Director acquired 10,000 shares (option exercise)
  19. 4 Open-market buy Director bought 3,000 shares at $7.14 ($21,431)
  20. 4 Option exercise Director acquired 5,000 shares (option exercise)

Page 5 of 13 · 256 filings